Wheeler Bio is a contract development and manufacturing organization, or CDMO, that specializes in batch clinical production of biologics and Good Manufacturing Process-grade, or GMP, reagents using an open-source platform.
The company, launched in 2021 by CEO Jesse McCool along with co-founder Christian Kanady, is a part of Oklahoma City’s growing biotech hub, housed in the 35,000-square-foot Ziggurat building in downtown Oklahoma City.
McCool and Kanady intend to accelerate the translation of therapeutic innovation into clinical effect.
According to an Oxford University journal article, Chinese hamster ovary cells are used widely for producing biopharmaceuticals, and engineering gene expression in those cells is key to improving drug quality and affordability.